SS Innovations International (NASDAQ:SSII) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of SS Innovations International (NASDAQ:SSII) from a sell rating to a hold rating in a report issued on Saturday morning.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, SS Innovations International has a consensus rating of “Sell”.

SS Innovations International Price Performance

SS Innovations International stock opened at $3.86 on Friday. SS Innovations International has a one year low of $3.02 and a one year high of $11.87. The business has a fifty day moving average price of $4.58 and a 200-day moving average price of $5.27. The firm has a market capitalization of $772.50 million and a P/E ratio of -77.20.

SS Innovations International (NASDAQ:SSII) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.02) EPS for the quarter. SS Innovations International had a negative return on equity of 23.00% and a negative net margin of 20.69%.The company had revenue of $11.10 million during the quarter.

Insiders Place Their Bets

In related news, Director Timothy P. Adams bought 300,000 shares of the stock in a transaction that occurred on Friday, March 6th. The shares were acquired at an average cost of $3.99 per share, with a total value of $1,197,000.00. Following the completion of the purchase, the director directly owned 5,331,902 shares of the company’s stock, valued at $21,274,288.98. This trade represents a 5.96% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Srivastava Sudhir bought 498,753 shares of the company’s stock in a transaction on Friday, March 6th. The shares were bought at an average price of $4.01 per share, with a total value of $1,999,999.53. Following the completion of the transaction, the chief executive officer owned 109,851,767 shares of the company’s stock, valued at $440,505,585.67. The trade was a 0.46% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired 1,300,006 shares of company stock worth $5,196,999 in the last ninety days.

Institutional Investors Weigh In On SS Innovations International

Hedge funds have recently bought and sold shares of the stock. PNC Financial Services Group Inc. purchased a new stake in shares of SS Innovations International during the 3rd quarter valued at $56,000. Envestnet Asset Management Inc. purchased a new position in shares of SS Innovations International in the 3rd quarter worth about $71,000. Jane Street Group LLC purchased a new position in shares of SS Innovations International in the 4th quarter worth about $63,000. IFC & Insurance Marketing Inc. purchased a new position in shares of SS Innovations International in the 4th quarter worth about $64,000. Finally, Goldman Sachs Group Inc. purchased a new position in shares of SS Innovations International in the 4th quarter worth about $68,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.